Currently, serum levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are commonly used to help in the diagnosis and prognosis of CCA, but these are unreliable due to their low sensitivity and specificity, especially for early stages of the disease [10,11]. Here, CEACAM5 is linked to cholangiocarcinoma.